MEDiC Life Sciences (MEDiC) is a SF Bay Area startup focused on discovering novel drug targets and biomarkers for solid cancers. Their proprietary CRISPR functional genomics platform, using patient-tumor-like cancer models, revolutionizes functional information accuracy and translatability. Internally, MEDiC drives drug programs for hepatocellular carcinoma and triple negative breast cancer. Additionally, they collaborate with oncology partners to deliver optimal targets and biomarkers for other solid tumor indications. With cutting-edge technology and strategic alliances, MEDiC is leading the charge in advancing cancer research and improving patient outcomes.